GSK sales reps were trained to offer sexual bribes

China |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

Singapore: Yet another list of shocking insights into the investigation of British drug maker GlaxoSmithKline's bribery scandal has been revealed by the Chinese police. The police have clai...Read more

Uscom signs deal to distribute its devices in China

China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2013

Singapore: Australia-based Uscom (Ultrasonic Cardiac Output Monitor) has gained a foothold into the rapidly growing Chinese medical device market after reaching an agreement with China Pion...Read more

WuXi PharmaTech facility gets accreditation

China |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

Singapore: Pharmaceutical, biotechnology and medical device research and development outsourcing company WuXi PharmaTech's Suzhou toxicology facility, with operations in China and the US, h...Read more

ShangPharma retains J P Morgan as financial advisor

China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

Singapore: The independent committee of the ShangPharma's board of directors retained J P Morgan Securities as its financial advisor. ShangPharma, which is a leading China-based pharmaceut...Read more

China drug market to reach $315 bn by 2020

China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

Singapore: Research and consulting firm GlobalData has pointed out that although various probes into drug pricing and sales practices have plagued China recently, the value of the country's...Read more

Gerresheimer net income rises by 22%

China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

Singapore: Gerresheimer, one-of-the-leading worldwide partners of the pharma and healthcare industry, has closed the 2012 financial year with significant growth in revenues and profits. Ger...Read more

H7N9 claims more lives in China

China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2014

Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new human cases of H7N9 Avian Influenza in four Chinese provinces. The de...Read more

Trifecta joins clinical research training consortium

China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

Singapore: Trifecta Clinical joined the board of directors for the Asia Training Consortium (ATC), which is a group of pharmaceutical companies, clinical research organizations and regiona...Read more

Dynex DSX ELISA gets China FDA nod

China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

Singapore: Dynex Technologies received approval from China's Food and Drug Administration (CFDA) to market the DSX automated enzyme-linked immunosorbent assay (ELISA) processing system in C...Read more

Cure for Osteogenesis now in China, Hong Kong

China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jun, 2014

Singapore: Italian based Abiogen Pharma signed an agreement with Lee's Pharmaceutical Holdings of Hong Kong, securing license for distribution and supply of neridronic acid in mainland Chin...Read more

Winteam acquires Tongjitang for $431 mn

China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

Singapore: Winteam Pharmaceutical Group has made an announcement confirming its acquisition of the entire issued share capital of Tongjitang Chinese Medicines for $431.27 million (2.64 bill...Read more

JenaValve raises $63 mn, eyes US, China markets

China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

Singapore: Germany-based JenaValve has raised nearly $63 million for its transcatheter aortic valve implant and announced its plans to enter the Transcatheter Aortic Valve Implantation (TAV...Read more

Chinese and big pharma to meet in Suzhou

China |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Singapore: The international biotech and pharma community will converge on Suzhou, China, for the ChinaBio Partnering Forum 2012, held at the Kempinski Hotel Suzhou, May 23-24. Co-organizer...Read more

GSK China scandal: New exposé, more murk

China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

Singapore: In what has been dubbed as the biggest corruption scandal to implicate a foreign company in China, the GlaxoSmithKline case has now come out in the open again. The company is sa...Read more

Otsuka, Lundbeck files NDA for schizophrenia drug

China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

H10N8 strain of bird flu not a threat to humans'

China |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

Singapore: The World Health Organization (WHO) has declared that H10N8 strain of the continually evolving avian influenza virus is not a current threat to public health. H10N8 is a descenda...Read more

CCBC completes $50 mn convertible notes financing with Golden Meditech

China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: China Cord Blood Corporation (CCBC), the first and largest cord blood banking operator in China, has successfully completed the previously announced $50 million convertible note...Read more

Focus on needs of society: Dr Weidong Yin

China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of the Year Award for 2011. Sinovac was established in 2001 with a missio...Read more